Answers are grounded in this paper and cite their sources.
Prospective cohort identifies baseline NIHSS as key predictor of poor functional outcome in young adults with ischemic stroke, suggesting need for tailored interventions.
Background and aims Between 9-15% of ischemic strokes affect young adults (18-55 years), representing a substantial socioeconomic burden, with an increasing incidence reported in recent years. The aim of our study was to characterize risk factors, clinical presentation, etiology, acute-phase treatments and functional outcomes in this population. Methods We conducted a multicenter, prospective observational study including patients aged 18-55 years evaluated as Stroke Codes in two Stroke Units in the Valencian Community (Spain) between December 2023 and April 2025. A total of 76 demographic, clinical, laboratory, imaging, therapeutic and functional variables were collected. Results A total of 184 patients were included (median age 49 years; 64% men). There was a high prevalence of traditional vascular risk factors (smoking 49%, obesity 45%, hypertension 41%) coexisting with non-classical factors (autoimmunity 10%, cannabis use 10%). Median baseline NIHSS was 9, showing a significant correlation with the 90-day mRS (ρ=0.41; p<0.001). 63% received reperfusion therapy in the acute phase. At discharge, 41% had an undetermined etiology and 21% uncommon etiology; after follow-up, 24% of initially undetermined were reclassified as uncommon etiology. Among biomarkers, D-dimer showed the strongest association with baseline NIHSS (r=0.61), highlighting the interplay between procoagulant and inflammatory pathways. In the multivariable model, baseline NIHSS was the strongest predictor of poor functional outcome (OR=1.07; p=0.03; AUC=0.74). Conclusions Young adults with ischemic stroke exhibit a high burden of vascular risk factors and heterogeneous etiologies requiring a broader diagnostic work-up. Baseline NIHSS emerged as the main predictor of poor functional outcome in our cohort. Conflict of interest Diana Lucía Tarruella Hernández: this study was supported by the Spanish Society of Neurology "Proyecto Ictus 2023" grant, awarded by the Cerebrovascular Diseases Study Group; no personal conflicts of interest to disclose.
No takes yet. Share an insight, caveat, or question.
Hernández et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: